{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:03:17Z","timestamp":1761894197940},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1990,3,1]],"date-time":"1990-03-01T00:00:00Z","timestamp":636249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1990,3]]},"DOI":"10.1007\/bf02244604","type":"journal-article","created":{"date-parts":[[2005,11,14]],"date-time":"2005-11-14T21:45:09Z","timestamp":1132004709000},"page":"345-349","source":"Crossref","is-referenced-by-count":38,"title":["Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl"],"prefix":"10.1007","volume":"100","author":[{"given":"Graham P.","family":"Luscombe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel A.","family":"Slater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan D.","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monte L.","family":"Scheinbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Roger Buckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02244604_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00432735","volume":"74","author":"A \u00c5berg-Wistedt","year":"1981","unstructured":"\u00c5berg-Wistedt A, Jostell K-G, Ross SB, Westerlund D (1981) Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression. Psychopharmacology 74:297\u2013305","journal-title":"Psychopharmacology"},{"key":"BF02244604_CR2","volume-title":"Statistical methods in medical research","author":"P Armitage","year":"1971","unstructured":"Armitage P (1971) Statistical methods in medical research. Blackwell, Oxford"},{"key":"BF02244604_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cpt1977212201","volume":"21","author":"M \u00c5sberg","year":"1977","unstructured":"\u00c5sberg M, Ringberger V-A, Sj\u00f6qvist F, Thor\u00e9n P, Tr\u00e4skman L, Tuck JR (1977) Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine. Clin Pharmacol Ther 21:201\u2013207","journal-title":"Clin Pharmacol Ther"},{"key":"BF02244604_CR4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/268455a0","volume":"268","author":"SP Banerjee","year":"1977","unstructured":"Banerjee SP, Kung LS, Riggi SJ, Chanda SK (1977) Development of \u03b2-adrenergic receptor subsensitivity by antidepressants. Nature 268:455\u2013456","journal-title":"Nature"},{"key":"BF02244604_CR5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00874660","volume":"18","author":"L Bertilsson","year":"1980","unstructured":"Bertilsson L, Tuck JR, Siwers B (1980) Biochemical effects of zimelidine in man. Eur J Clin Pharmacol 18:483\u2013487","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02244604_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-349-09506-3_13","volume-title":"New concepts in depression","author":"WR Buckett","year":"1988","unstructured":"Buckett WR, Luscombe GP, Thomas PC (1988a) BTS 54 524 an approach to a rapidly acting antidepressant. In: Briley M, Fillion G (eds) New concepts in depression. Macmillan, London, pp 167\u2013172"},{"key":"BF02244604_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0278-5846(88)90003-6","volume":"12","author":"WR Buckett","year":"1988","unstructured":"Buckett WR, Thomas PC, Luscombe GP (1988b) The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antide-pressant which induces rapid noradrenergic down-regulation. Prog Neuropsychopharmacol Biol Psychiatry 12:575\u2013584","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF02244604_CR8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-4159.1989.tb07389.x","volume":"53","author":"DJ Heal","year":"1989","unstructured":"Heal DJ, Butler SA, Hurst EM, Buckett WR (1989) Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease \u03b21-but not \u03b22-adrenoceptors in rat cortex. J Neurochem 53:1019\u20131025","journal-title":"J Neurochem"},{"key":"BF02244604_CR9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0278-5846(82)80179-6","volume":"6","author":"J Hyttel","year":"1982","unstructured":"Hyttel J (1982) Citalopram \u2014 pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6:277\u2013295","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF02244604_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00004714-198404020-00003","volume":"4","author":"O Lingjaerde","year":"1984","unstructured":"Lingjaerde O (1984) Platelet serotonin uptake inhibition as a basis for monitoring antidepressant drug treatment. J Clin Psychopharmacol 4:76\u201381","journal-title":"J Clin Psychopharmacol"},{"key":"BF02244604_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0028-3908(89)90048-8","volume":"28","author":"GP Luscombe","year":"1989","unstructured":"Luscombe GP, Hopcroft RH, Thomas PC, Buckett WR (1989) The contribution of metabolites to the rapid and potent down-regulation of rat cortical \u03b2-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology 28:129\u2013134","journal-title":"Neuropharmacology"},{"key":"BF02244604_CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0447.1986.tb10578.x","volume":"73","author":"C Nystr\u00f6m","year":"1986","unstructured":"Nystr\u00f6m C, Ross SB, H\u00e4llstr\u00f6m T, Kelder D (1986) Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed patients. Acta Psychiatr Scand 73:133\u2013138","journal-title":"Acta Psychiatr Scand"},{"key":"BF02244604_CR13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.6251550","volume":"210","author":"SJ Peroutka","year":"1980","unstructured":"Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88\u201390","journal-title":"Science"},{"key":"BF02244604_CR14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-2999(84)90403-5","volume":"104","author":"E Richelson","year":"1984","unstructured":"Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277\u2013286","journal-title":"Eur J Pharmacol"},{"key":"BF02244604_CR15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00433405","volume":"79","author":"SB Ross","year":"1983","unstructured":"Ross SB, \u00c5berg-Wistedt A (1983) Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment. Psychopharmacology 79:298\u2013303","journal-title":"Psychopharmacology"},{"key":"BF02244604_CR16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-0773.1975.tb00806.x","volume":"36","author":"SB Ross","year":"1975","unstructured":"Ross SB, Renyi AL (1975) Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of3H-noradrenaline and14C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. Acta Pharmacol Toxicol 36:382\u2013394","journal-title":"Acta Pharmacol Toxicol"},{"key":"BF02244604_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0028-3908(77)90048-X","volume":"16","author":"SB Ross","year":"1977","unstructured":"Ross SB, Renyi AL (1977) Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)-and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl)allylamines and their secondary analogues. Neuropharmacology 16:57\u201363","journal-title":"Neuropharmacology"},{"key":"BF02244604_CR18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cpt1977212194","volume":"21","author":"B Siwers","year":"1977","unstructured":"Siwers B, Ringberger V-A, Tuck JR, Sj\u00f6qvist F (1977) Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients. Clin Pharmacol Ther 21:194\u2013200","journal-title":"Clin Pharmacol Ther"},{"key":"BF02244604_CR19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/cpt1979265600","volume":"26","author":"L Tr\u00e4skman","year":"1979","unstructured":"Tr\u00e4skman L, \u00c5sberg M, Bertilsson L, Cronholm B, Mellstr\u00f6m B, Neckers LM, Sj\u00f6qvist F, Thor\u00e9n P, Tybring G (1979) Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression. Clin Pharmacol Ther 26:600\u2013610","journal-title":"Clin Pharmacol Ther"},{"key":"BF02244604_CR20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.2042-7158.1973.tb09160.x","volume":"25","author":"JR Tuck","year":"1973","unstructured":"Tuck JR, Punell G (1973) Uptake of [3H]5-hydroxytryptamine and [3H]noradrenaline by slices of rat brain incubated in plasma from patients treated with chlorimipramine, imipramine or amitriptyline. J Pharm Pharmacol 25:573\u2013574","journal-title":"J Pharm Pharmacol"},{"key":"BF02244604_CR21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00427639","volume":"69","author":"J Tuomisto","year":"1980","unstructured":"Tuomisto J, Tukiainen E, Voutilainen R, Tuomainen P (1980) Inhibition of 5-hydroxytryptamine and noradrenaline uptake in platelets and synaptosomes incubated in plasma from human subjects treated with amitriptyline or nortriptyline: utilization of the principle for a bioassay method. Psychopharmacology 69:137\u2013142","journal-title":"Psychopharmacology"},{"key":"BF02244604_CR22","volume-title":"Statistical principles in experimental design","author":"BJ Winer","year":"1971","unstructured":"Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York","edition":"2nd edn."}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02244604\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T23:32:04Z","timestamp":1557876724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02244604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1990,3]]}},"alternative-id":["BF02244604"],"URL":"https:\/\/doi.org\/10.1007\/bf02244604","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,3]]}}}